CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

Abroad (travel likely)RecruitingPHASE4

Conditions

Coronary · Coronary Artery Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • West China Hospital of Sichuan University, Chengdu, Sichuan, China

Study leads
  • Yong He

    Study Director

    West China Hospital